Also from this source

You just read:

U.S. Nephrologists Report a Decreasing Trend in the Treatment Prevalence of ESAs; Physicians Find High Interest in HIF Inhibitors SFP, Zerenex and CTAP101

News provided by

BioTrends Research Group

Jan 14, 2013, 08:00 EST